Shell Asset Management’s Guardant Health GH Stock Holding History

Shell Asset Management’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$55K	Sell	884 -1,198	-58%	-$65.2K	0.01%	834
2025 Q2	$108K	Sell	2,082 -644	-24%	-$28.8K	﹤0.01%	980
2025 Q1	$116K	Sell	2,726 -214	-7%	-$9.23K	0.01%	976
2024 Q4	$90K	Hold	2,940	–	–	﹤0.01%	1065
2024 Q3	$67K	Buy	+2,940	New	+$83.2K	﹤0.01%	1136
2024 Q1	$90K	Sell	3,107 -257	-8%	-$5.51K	﹤0.01%	1047
2023 Q4	$91K	Sell	3,364 -1,012	-23%	-$26.5K	﹤0.01%	1089
2023 Q3	$130K	Sell	4,376 -69	-2%	-$2.43K	0.01%	1028
2023 Q2	$159K	Sell	4,445 -26	-0.6%	-$747	0.01%	995
2023 Q1	$105K	Sell	4,471 -16	-0.4%	-$457	﹤0.01%	1092
2022 Q4	$122K	Sell	4,487 -879	-16%	-$40.2K	0.01%	1108
2022 Q3	$289K	Sell	5,366 -1,413	-21%	-$72.5K	0.01%	850
2022 Q2	$273K	Buy	6,779 +6	+0.1%	+$297	0.01%	1022
2022 Q1	$449K	Sell	6,773 -1,006	-13%	-$68.8K	0.01%	861
2021 Q4	$778K	Buy	7,779 +44	+0.6%	+$4.55K	0.02%	693
2021 Q3	$967K	Sell	7,735 -330	-4%	-$39.2K	0.02%	530
2021 Q2	$1M	Buy	+8,065	New	+$1.08M	0.02%	568

Other funds holding GH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Shell Asset Management's GH Position: Q3 2025 in Review

Shell Asset Management reduced its Guardant Health (GH) stake by 58% in Q3 2025, selling an estimated $65.2K and leaving 884 shares worth $55K. The position accounts for 0.01% of the portfolio, ranked #834.

Shell Asset Management first reported a position in GH in Q2 2021 and has held it in 17 quarters since. The position peaked at $1M in Q2 2021. 395 funds tracked by Wall St. Rank hold GH as of Q3 2025.

Shell Asset Management held 884 shares of Guardant Health worth $55K as of Q3 2025.
Shell Asset Management sold 1,198 Guardant Health shares in Q3 2025, an estimated $65.2K.
Guardant Health made up 0.01% of Shell Asset Management's portfolio in Q3 2025, its #834 holding.
Shell Asset Management first reported a position in Guardant Health in Q2 2021 and has held it in 17 quarters since.
Shell Asset Management's Guardant Health position peaked at $1M in Q2 2021.
395 funds tracked by Wall St. Rank held Guardant Health as of Q3 2025.

Based on Shell Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.